Betulinic acid-induced apoptosis in leukemia cells

被引:116
作者
Ehrhardt, H
Fulda, S
Führer, M
Debatin, KM
Jeremias, I
机构
[1] Dr Von Haunerschen Kinderspital, Dept Hematol Oncol, Munich, Germany
[2] Univ Ulm, Univ Clin & Policlin Children & Adolescents, Ulm, Germany
关键词
betulinic acid; leukemia; apoptosis;
D O I
10.1038/sj.leu.2403406
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Betulinic acid (BA), a natural component isolated from Birch trees, effectively induces apoptosis in neuroectodermal and epithelial tumor cells and exerts little toxicity in animal trials. Here, we show that BA-induced marked apoptosis in 65% of primary pediatric acute leukemia cells and all leukemia cell lines tested. When compared for in vitro efficiency with conventionally used cytotoxic drugs, BA was more potent than nine out of 10 standard therapeutics and especially efficient in tumor relapse. No crossresistances were found between BA and any cytotoxic drug. Intracellular apoptosis signaling in leukemia tumor cells paralleled the pathway found in neuroectodermal cells involving caspases, but not death receptors. In isolated mitochondria, BA induced release of both cytochrome c and Smac. Taken together, BA potently induces apoptosis in leukemia cells and should be further evaluated as a future drug to treat leukemia.
引用
收藏
页码:1406 / 1412
页数:7
相关论文
共 22 条
[11]   Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid [J].
Fulda, S ;
Scaffidi, C ;
Susin, SA ;
Krammer, PH ;
Kroemer, G ;
Peter, ME ;
Debatin, KM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (51) :33942-33948
[12]   Somatic mutagenesis studies of NF-κB signaling in human T cells:: evidence for an essential role of IKKγ in NF-κB activation by T-cell costimulatory signals and HTLV-I Tax protein [J].
Harhaj, EW ;
Good, L ;
Xiao, GT ;
Uhlik, M ;
Cvijic, ME ;
Rivera-Walsh, I ;
Sun, SC .
ONCOGENE, 2000, 19 (11) :1448-1456
[13]   PHARMACOKINETICS OF CYTOSINE-ARABINOSIDE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA [J].
HARRIS, AL ;
POTTER, C ;
BUNCH, C ;
BOUTAGY, J ;
HARVEY, DJ ;
GRAHAMESMITH, DG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (03) :219-227
[14]  
HENDERSON PJ, 1970, J BIOL CHEM, V245, P1319
[15]   Development of C-20 modified betulinic acid derivatives as antitumor agents [J].
Kim, JY ;
Koo, HM ;
Kim, DSHL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (17) :2405-2408
[16]  
Kitchen BJ, 1997, CLIN CANCER RES, V3, P713
[17]   DISCOVERY OF BETULINIC ACID AS A SELECTIVE INHIBITOR OF HUMAN-MELANOMA THAT FUNCTIONS BY INDUCTION OF APOPTOSIS [J].
PISHA, E ;
CHAI, H ;
LEE, IS ;
CHAGWEDERA, TE ;
FARNSWORTH, NR ;
CORDELL, GA ;
BEECHER, CWW ;
FONG, HHS ;
KINGHORN, AD ;
BROWN, DM ;
WANI, MC ;
WALL, ME ;
HIEKEN, TJ ;
DASGUPTA, TK ;
PEZZUTO, JM .
NATURE MEDICINE, 1995, 1 (10) :1046-1051
[18]   Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIα [J].
Syrovets, T ;
Büchele, B ;
Gedig, E ;
Slupsky, JR ;
Simmet, T .
MOLECULAR PHARMACOLOGY, 2000, 58 (01) :71-81
[19]   RIP mediates tumor necrosis factor receptor 1 activation of NF-kappa B but not Fas/APO-1-initiated apoptosis [J].
Ting, AT ;
PimentelMuinos, FX ;
Seed, B .
EMBO JOURNAL, 1996, 15 (22) :6189-6196
[20]   BLOOD LEVEL AND URINARY-EXCRETION OF ACTIVATED CYCLOPHOSPHAMIDE AND ITS DEACTIVATION PRODUCTS IN MAN [J].
WAGNER, T ;
HEYDRICH, D ;
VOELCKER, G ;
HOHORST, HJ .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1980, 96 (01) :79-92